* Announces pricing of $15 billion of senior notes in
connection with pending acquisition of Actavis Generics
The post BRIEF-Teva Pharmaceutical announces pricing of $15 bln of senior notes appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Announces pricing of $15 billion of senior notes in
connection with pending acquisition of Actavis Generics
The post BRIEF-Teva Pharmaceutical announces pricing of $15 bln of senior notes appeared first on NASDAQ.